Description

Erlocip Erlotinib 150mg Tablets: Uses, Side Effects, and Precautions

Erlocip Erlotinib 150mg Tablets are used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. This targeted therapy works by inhibiting epidermal growth factor receptor (EGFR) activity, preventing cancer cells from growing and spreading.

Dosage and Administration

Taken orally once daily, at least 1 hour before or 2 hours after meals.
Dosage may vary based on individual response and medical condition.
Consistency in timing improves effectiveness.

Common Side Effects

Skin rash
Diarrhea
Nausea
Fatigue

Serious Side Effects

Severe lung problems (shortness of breath, coughing)
Liver toxicity (jaundice, dark urine)
Gastrointestinal bleeding
Eye irritation or vision changes
Seek medical attention for severe reactions.

Precautions and Warnings

Avoid grapefruit and smoking, as they may reduce drug effectiveness.
Use with caution in individuals with liver or kidney disease.
Pregnant or breastfeeding individuals should consult a doctor.
Regular monitoring of liver function and lung health is necessary.

Disclaimer:

Products information mentioned on this site is for informative purposes only. The product image belongs to the respective company. Genetec Lifesciences is a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.